Skip to main content
Erschienen in: Lasers in Medical Science 3/2017

16.02.2017 | Original Article

Non-ablative erbium YAG laser for the treatment of type III stress urinary incontinence (intrinsic sphincter deficiency)

verfasst von: Adrian Gaspar, Hugo Brandi

Erschienen in: Lasers in Medical Science | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

The objective of this pilot study was to determine the safety and efficacy of a new non-ablative erbium YAG laser procedure for the treatment of type III stress urinary incontinence (intrinsic sphincter deficiency) in women. Twenty-two patients with a Valsalva leak point pressure less than 60 cm H2O were recruited and treated with a non-ablative erbium laser delivering low fluence pulses inside the whole length of the urethra through a specially designed cannula. Treatment consisted of two treatment sessions with a 3-week interval in-between. Therapeutic efficacy, as assessed by a questionnaire addressing quality of life during urinary incontinence and the 1-h pad test, was measured at 3 and 6 months after the procedure. Both methods of assessment showed similar levels of improvement in terms of incontinence severity and improvement in quality of life. All patients tolerated the therapy well and adverse effects were mild and transient. The results of this pilot study showed significant improvement of type III stress urinary incontinence. Despite the limitations of this study, being small patient number and short follow-up, this non-ablative intraurethral erbium YAG laser procedure seems to be a safe and efficacious alternative for patients with type III stress urinary incontinence. More controlled studies should be performed to confirm this data and to evaluate the long-term effects.
Literatur
2.
Zurück zum Zitat Abrams P, Cardozo L, Fall M et al (2002) The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21:167–178CrossRefPubMed Abrams P, Cardozo L, Fall M et al (2002) The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21:167–178CrossRefPubMed
3.
Zurück zum Zitat McGuire EJ, Fitzpatrick CC, Wan J et al (1993) Clinical assessment of urethral sphincter function. J Urol 150:1452–1454PubMed McGuire EJ, Fitzpatrick CC, Wan J et al (1993) Clinical assessment of urethral sphincter function. J Urol 150:1452–1454PubMed
4.
Zurück zum Zitat Lane TM, Shah PJR (2000) Valsalva leak point pressure in the evaluation of stress urinary incontinence. Braz J Urol 26:420–425 Lane TM, Shah PJR (2000) Valsalva leak point pressure in the evaluation of stress urinary incontinence. Braz J Urol 26:420–425
5.
Zurück zum Zitat Ford AA, Ogah JA (2016) Retropubic or transobturator mid-urethral slings for intrinsic sphincter deficiency-related stress urinary incontinence in women: a systematic review and meta-analysis. Int Urogynecol J 27:19–28. doi:10.1007/s00192-015-2797-3 CrossRefPubMed Ford AA, Ogah JA (2016) Retropubic or transobturator mid-urethral slings for intrinsic sphincter deficiency-related stress urinary incontinence in women: a systematic review and meta-analysis. Int Urogynecol J 27:19–28. doi:10.​1007/​s00192-015-2797-3 CrossRefPubMed
7.
Zurück zum Zitat Balmforth J, Cardozo LD (2003) Trends toward less invasive treatment of female stress urinary incontinence. Urology 62:52–60CrossRefPubMed Balmforth J, Cardozo LD (2003) Trends toward less invasive treatment of female stress urinary incontinence. Urology 62:52–60CrossRefPubMed
9.
Zurück zum Zitat Bump RC, Coates KW, Cundiff GW et al (1997) Diagnosing intrinsic sphincteric deficiency: comparing urethral closure pressure, urethral axis, and Valsalva leak point pressures. Am J Obstet Gynecol 177:303–310CrossRefPubMed Bump RC, Coates KW, Cundiff GW et al (1997) Diagnosing intrinsic sphincteric deficiency: comparing urethral closure pressure, urethral axis, and Valsalva leak point pressures. Am J Obstet Gynecol 177:303–310CrossRefPubMed
11.
Zurück zum Zitat Vizintin Z, Rivera M, Fistonić I et al (2012) Novel minimally invasive VSP Er:YAG laser treatments in gynecology. 2012:46–58 Vizintin Z, Rivera M, Fistonić I et al (2012) Novel minimally invasive VSP Er:YAG laser treatments in gynecology. 2012:46–58
12.
Zurück zum Zitat Majaron B, Srinivas SM, Huang HE, Nelson JS (2000) Deep coagulation of dermal collagen with repetitive Er:YAG laser irradiation. Lasers Surg Med 26:215–222CrossRefPubMed Majaron B, Srinivas SM, Huang HE, Nelson JS (2000) Deep coagulation of dermal collagen with repetitive Er:YAG laser irradiation. Lasers Surg Med 26:215–222CrossRefPubMed
14.
Zurück zum Zitat Gaviria J, Lanz J (2012) Laser vaginal tightening (LVT)—evaluation of a novel noninvasive laser treatment for vaginal relaxation syndrome. J Laser Heal Acad 1:59–66 Gaviria J, Lanz J (2012) Laser vaginal tightening (LVT)—evaluation of a novel noninvasive laser treatment for vaginal relaxation syndrome. J Laser Heal Acad 1:59–66
16.
Zurück zum Zitat Fistonic N, Fistonic I, Gustek SF et al (2016) Minimally invasive, non-ablative Er:YAG laser treatment of stress urinary incontinence in women-a pilot study. Lasers Med Sci 1–9. doi:10.1007/s10103-016-1884-0 Fistonic N, Fistonic I, Gustek SF et al (2016) Minimally invasive, non-ablative Er:YAG laser treatment of stress urinary incontinence in women-a pilot study. Lasers Med Sci 1–9. doi:10.​1007/​s10103-016-1884-0
18.
Zurück zum Zitat Gaspar A, Brandi H, Gomez V, Luque D (2016) Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause. Lasers Surg Med. doi:10.1002/lsm.22569 PubMed Gaspar A, Brandi H, Gomez V, Luque D (2016) Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause. Lasers Surg Med. doi:10.​1002/​lsm.​22569 PubMed
19.
21.
Zurück zum Zitat Klarskov P, Hald T (1984) Reproducibility and reliability of urinary incontinence assessment with a 60 min test. Scand J Urol Nephrol 18:293–298CrossRefPubMed Klarskov P, Hald T (1984) Reproducibility and reliability of urinary incontinence assessment with a 60 min test. Scand J Urol Nephrol 18:293–298CrossRefPubMed
22.
Zurück zum Zitat U.S. Department of Health and Human Services, Administration F and D, Health C for D and R (2011) Guidance for Industry and Food and Drug Administration Staff Clinical Investigations of Devices Indicated for the Treatment of Urinary Incontinence U.S. Department of Health and Human Services, Administration F and D, Health C for D and R (2011) Guidance for Industry and Food and Drug Administration Staff Clinical Investigations of Devices Indicated for the Treatment of Urinary Incontinence
23.
Zurück zum Zitat Lukanovic A, Blaganje M, Scepanovic D, Zgur L (2014) Laser thermotherapy in pelvic floor dysfunction, randomised placebo controled study. Neurourol Urodyn 33 Lukanovic A, Blaganje M, Scepanovic D, Zgur L (2014) Laser thermotherapy in pelvic floor dysfunction, randomised placebo controled study. Neurourol Urodyn 33
25.
Zurück zum Zitat Moritz AR, Henriques FC (1947) Studies of thermal injury: II. The relative importance of time and surface temperature in the causation of cutaneous burns. Am J Pathol 23:695–720PubMedPubMedCentral Moritz AR, Henriques FC (1947) Studies of thermal injury: II. The relative importance of time and surface temperature in the causation of cutaneous burns. Am J Pathol 23:695–720PubMedPubMedCentral
26.
Zurück zum Zitat Capon A, Mordon S (2003) Can thermal lasers promote skin wound healing? Am J Clin Dermatol 4:1–12CrossRefPubMed Capon A, Mordon S (2003) Can thermal lasers promote skin wound healing? Am J Clin Dermatol 4:1–12CrossRefPubMed
27.
Zurück zum Zitat Simons AM, Yoong WC, Buckland S, Moore KH (2001) Inadequate repeatability of the one-hour pad test: the need for a new incontinence outcome measure. Br J Obstet Gynaecol 108:315–319. doi:10.1016/S0306-5456(00)00069-3 Simons AM, Yoong WC, Buckland S, Moore KH (2001) Inadequate repeatability of the one-hour pad test: the need for a new incontinence outcome measure. Br J Obstet Gynaecol 108:315–319. doi:10.​1016/​S0306-5456(00)00069-3
28.
Zurück zum Zitat Costantini E, Lazzeri M, Bini V et al (2008) Sensitivity and specificity of one-hour pad test as a predictive value for female urinary incontinence. Urol Int 81:153–159. doi:10.1159/000144053 CrossRefPubMed Costantini E, Lazzeri M, Bini V et al (2008) Sensitivity and specificity of one-hour pad test as a predictive value for female urinary incontinence. Urol Int 81:153–159. doi:10.​1159/​000144053 CrossRefPubMed
29.
30.
32.
Metadaten
Titel
Non-ablative erbium YAG laser for the treatment of type III stress urinary incontinence (intrinsic sphincter deficiency)
verfasst von
Adrian Gaspar
Hugo Brandi
Publikationsdatum
16.02.2017
Verlag
Springer London
Erschienen in
Lasers in Medical Science / Ausgabe 3/2017
Print ISSN: 0268-8921
Elektronische ISSN: 1435-604X
DOI
https://doi.org/10.1007/s10103-017-2170-5

Weitere Artikel der Ausgabe 3/2017

Lasers in Medical Science 3/2017 Zur Ausgabe